The anti-programmed death receptor 1 (PD-1) monotherapy Jemperli (dostarlimab) received
Read more
familyhealthtale.com
Home »
The anti-programmed death receptor 1 (PD-1) monotherapy Jemperli (dostarlimab) received
Read more(HealthDay)—The U.S. Food and Drug Administration on Friday approved the
Read moreSri Lanka on Friday approved the Oxford-AstraZeneca vaccine for COVID-19
Read moreMONDAY, Dec. 14, 2020 — The first genetically engineered pigs
Read moreTUESDAY, Sept. 29, 2020 — The U.S. Food and Drug
Read moreA new saliva test for COVID-19 that can be completed
Read moreSpravato, a mind-altering medication related to the club drug Special
Read moreTHURSDAY, Nov. 29, 2018 — Firdapse (amifampridine) tablets have been
Read moreWEDNESDAY, Oct. 24, 2018 — For the first time in
Read moreOn Friday, the U.S. Food and Drug Administration approved Annovera,
Read more